Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Post by rhdmdon Mar 11, 2013 5:48pm
113 Views
Post# 21113004

Clarification on scope of the NEWCO

Clarification on scope of the NEWCO

Hello Dr. XXXX

 

It is expected that all rights to develop, license and manufacture MCC will be granted to Bioniche Therapeutics Corp., beginning with the Urocidin-related rights.

 

Oncocidin is an animal health product that we plan to manufacture in our Montreal facility for Bioniche Animal Health. This arrangement will be accommodated with the new structure.

 

Sincerely,

Jennifer

 

Jennifer Shea

Vice-President, Communications, Investor & Government Relations

Bioniche Life Sciences Inc.

P.O. Box 1570, 231 Dundas St. E.

Belleville, Ontario

Canada  K8N 5J2

Phone: 613-966-8058 ext. 1250

Mobile: 613-391-2097

Fax: 613-966-4177

Bullboard Posts